2014 annual financial data
Tempest Therapeutics 2014 Operating cash flow margin
Direct answer
Operating cash flow margin was -314.21%.
Operating income was -47,933,000 USD and net income was -49,520,000 USD.
Operating cash flow was -30,588,000 USD.
Get free Tempest Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,735,000 USD
- Operating income
- -47,933,000 USD
- Net income
- -49,520,000 USD
- Operating cash flow
- -30,588,000 USD